Silverarc Capital Management, LLC Merus N.V. Transaction History

Silverarc Capital Management, LLC

$402 Million
Q3 2024

A detailed history of Silverarc Capital Management, LLC transactions in Merus N.V. stock. As of the latest transaction made, Silverarc Capital Management, LLC holds 635,439 shares of MRUS stock, worth $26.6 Million. This represents 7.9% of its overall portfolio holdings.

Number of Shares

635,439

Previous 623,628 1.89%

Holding current value

$26.6 Million

Previous $36.9 Million 13.97%

% of portfolio

7.9%

Previous 10.47%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$47.19 - $58.84 $557,361 - $694,959	11,811 Added 1.89%	635,439 $31.7 Million
Q2 2024 Aug 14, 2024	BUY	$39.81 - $60.2 $2.28 Million - $3.45 Million	57,341 Added 10.13%	623,628 $36.9 Million
Q1 2024 May 14, 2024	SELL	$28.03 - $51.82 $2.22 Million - $4.11 Million	-79,294 Reduced 12.28%	566,287 $25.5 Million
Q4 2023 Feb 14, 2024	BUY	$20.06 - $28.66 $2.92 Million - $4.17 Million	145,581 Added 29.12%	645,581 $17.8 Million
Q3 2023 Nov 13, 2023	SELL	$20.13 - $27.29 $1.8 Million - $2.44 Million	-89,255 Reduced 15.15%	500,000 $11.8 Million
Q2 2023 Aug 14, 2023	SELL	$18.33 - $27.18 $1.46 Million - $2.16 Million	-79,529 Reduced 11.89%	589,255 $15.5 Million
Q1 2023 May 15, 2023	BUY	$14.25 - $20.5 $5.62 Million - $8.08 Million	394,080 Added 143.46%	668,784 $12.3 Million
Q4 2022 Feb 14, 2023	SELL	$12.8 - $23.66 $261,529 - $483,421	-20,432 Reduced 6.92%	274,704 $4.25 Million
Q3 2022 Oct 28, 2022	SELL	$18.64 - $28.93 $3.24 Million - $5.03 Million	-173,977 Reduced 37.09%	295,136 $5.91 Million
Q2 2022 Jul 25, 2022	BUY	$13.98 - $29.25 $2.02 Million - $4.22 Million	144,394 Added 44.47%	469,113 $10.6 Million
Q1 2022 May 13, 2022	BUY	$23.58 - $30.91 $107,171 - $140,485	4,545 Added 1.42%	324,719 $8.59 Million
Q4 2021 Feb 14, 2022	SELL	$20.0 - $32.29 $515,800 - $832,759	-25,790 Reduced 7.45%	320,174 $10.2 Million
Q3 2021 Nov 15, 2021	BUY	$16.48 - $27.23 $414,455 - $684,807	25,149 Added 7.84%	345,964 $7.61 Million
Q2 2021 Aug 16, 2021	BUY	$20.0 - $25.48 $1.52 Million - $1.94 Million	76,102 Added 31.1%	320,815 $6.76 Million
Q1 2021 May 18, 2021	BUY	$16.14 - $29.11 $3.95 Million - $7.12 Million	244,713 New	244,713 $5.11 Million

Others Institutions Holding MRUS

# of Institutions

200

Shares Held

61.9M

Call Options Held

243K

Put Options Held

300K

View Full List

About Merus N.V.

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $1.92B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

More about MRUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverarc Capital Management, LLC with notifications on news.

Account

Silverarc Capital Management, LLC Merus N.V. Transaction History